Heyman Tomas J.
Related Filers (6)
- Akero Therapeutics, Inc. (7)
- OptiNose, Inc. (5)
- Invivyd, Inc. (3)
- Xilio Therapeutics, Inc. (3)
- EXELIXIS, INC. (2)
- Legend Biotech Corp (1)
- Show More ...
Other (2)
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
144
Friday, 6/16/2023
Filing for proposed sale of securities under Rule 144
Ownership (19)
4
Tuesday, 6/27/2023
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Wednesday, 6/21/2023
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Tuesday, 6/13/2023
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/9/2023
OptiNose, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/2/2023
EXELIXIS, INC.: Statement of changes in beneficial ownership of securities
3
Friday, 6/2/2023
EXELIXIS, INC.: Initial statement of beneficial ownership of securities
4
Thursday, 5/25/2023
Invivyd, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 9/16/2022
Xilio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 9/16/2022
Xilio Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Friday, 6/24/2022
Adagio Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/9/2022
OptiNose, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 6/3/2022
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 8/5/2021
Adagio Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/10/2021
OptiNose, Inc.: Statement of changes in beneficial ownership of securities
4
Thursday, 6/3/2021
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/4/2020
OptiNose, Inc.: Statement of changes in beneficial ownership of securities
3
Friday, 12/4/2020
OptiNose, Inc.: Initial statement of beneficial ownership of securities
3
Thursday, 6/11/2020
Akero Therapeutics, Inc.: Initial statement of beneficial ownership of securities
4
Thursday, 6/11/2020
Akero Therapeutics, Inc.: Statement of changes in beneficial ownership of securities